● Recruiting

Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer

Condition: Levonorgestrel · Intrauterine Systems · Prevention · Sponsor: M.D. Anderson Cancer Center

PhaseN/A

Planned participants270

Who can joinFemale, 18 Years to no upper limit

Healthy volunteersNo

About this study

To develop an educational tool to help patients and healthcare professionals make informed decisions about endometrial cancer and available prevention options for it (such as the use of a levonorgestrel-releasing intrauterine system \[LNG-IUS\]).

This description comes directly from the study's public registry record.

Talk to the study team

Larissa A Meyer, MD · 713-745-0973 · lmeyer@mdanderson.org

Always discuss trial participation with your own doctor first.

Locations (2)

The Harris Health System (LBJ)	Houston, Texas, United States	Recruiting
MD Anderson Cancer Center	Houston, Texas, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07382583